Guangdong, China

Linjing Li

This inventor holds 1 USPTO granted patent. Top assignee: Medprin Regenerative Medical Technologies Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linjing Li. Retrieved from https://idiyas.com/inventor/linjing-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Hemostasis: The Contributions of Linjing Li

Introduction

Linjing Li is a notable inventor based in Guangdong, China, recognized for his significant contributions to the field of medical materials. His work primarily focuses on developing innovative solutions for hemostatic applications, which are crucial in medical settings.

Latest Patents

Linjing Li holds a patent for a "Degradable and absorbable hemostatic fiber material, preparation method therefor, and hemostatic fiber article thereof." This invention features a hemostatic fiber material with a carboxylation degree of 10-25% and a polymerization degree of 10-250. The material comprises fiber filaments with a linear density ranging from 0.8 to 4.5 dtex and a dry strength of 10-150 cN/tex. The innovative design ensures that the hemostatic fiber material maintains a higher carboxylation degree and a lower polymerization degree, resulting in improved strength and effectiveness in hemostasis.

Career Highlights

Linjing Li is associated with Medprin Regenerative Medical Technologies Co., Ltd., where he continues to advance research and development in regenerative medical technologies. His work has been instrumental in creating safer and more effective medical materials that can be degraded and absorbed by the body.

Collaborations

Linjing Li collaborates with talented professionals in his field, including Guangyao Li and Kunxue Deng. Their combined expertise contributes to the innovative projects at Medprin Regenerative Medical Technologies Co., Ltd.

Conclusion

Linjing Li's contributions to the development of degradable and absorbable hemostatic materials represent a significant advancement in medical technology. His innovative approach not only enhances the effectiveness of hemostatic applications but also prioritizes patient safety through the use of biodegradable materials.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…